Dublin, Dec. 18, 2018 (GLOBE NEWSWIRE) -- The "Global Pharmacovigilance Market - Forecasts From 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
The global Pharmacovigilance market is expected to reach US$6.705 billion by 2023 from US$3.224 billion in 2017 growing at a CAGR of 12.98%.
The market is expected to show significant growth during the forecast period owing to the rising drug development and number of drugs under investigation. Rising incidences of the adverse drug reaction coupled with stringent government regulations to monitor them have also boosted the market for pharmacovigilance.
However, lack of patient data security and safety might hamper the growth of the pharmacovigilance market during the given time frame. Adopting a global approach for pharmacovigilance assessment has also been a major challenge for the pharmacovigilance industry.
Major industry players profiled as part of the report are Cognizant, Bioclinica and Kinapse among others.
Key Topics Covered
1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter's Five Forces Analysis
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. Global Pharmacovigilance Market Forecast by Clinical Trial Phase
5.1. Preclinical
5.2. Phase I
5.3. Phase II
5.4. Phase III
5.5. Phase IV (Post Marketing Surveillance)
6. Global Pharmacovigilance Market Forecast by Service Provider
6.1. Contract Outsourcing
6.2. In House
7. Global Pharmacovigilance Market Forecast by End Users
7.1. Pharmaceutical and Biopharmaceuticals
7.2. Medical Devices
8. Global Pharmacovigilance Market Forecast by Geography
8.1. North America
8.2. South America
8.3. Europe
8.4. Middle East and Africa
8.5. Asia Pacific
9. Competitive intelligence
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. Company Profiles
10.1. Eli Lilly and Company
10.2. Cognizant
10.3. Kinapse (A Syneos Health Company)
10.4. Sciformix (A Covance Company)
10.5. Quintiles IMS
10.6. Pharmaceutical Product Development LLC
10.7. Oviya MedSafe
10.8. APCER Life Sciences Inc.
10.9. Navitas Life Sciences
10.10. Bioclinica
For more information about this report visit https://www.researchandmarkets.com/research/wpjcnv/global?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.